Fountain Square III

HistoricalNet lease
Talk to a 1031 specialistData updated Jan 5, 2026
Offering size$32.0M
Asset typeNet Lease
LocationMulti-state
FinancingNot disclosed
Regulation D exemptionRule 506(c)
Sponsor-reported potential 721/UPREIT exitNo
First filedNov 3, 2025
Last filedJan 5, 2026
Minimum$50k

DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.

Documented outcome

Still operating, no exit yet

No public sale, full-cycle, or disposition announcement exists for REVA Fountain Square 3 DST; the Form D raise only closed Jan 5, 2026 (extremely recent), REVA's offerings page lists no Fountain Square 3 disposition, and JRW Investments' REVA sponsor page records 0 full-cycle offerings [1][2][3].

SEC filing recordMatched to public SEC filings
First filedNov 3, 2025
Latest filingJan 5, 2026
Filings tracked2
View filing on SEC EDGAR

Form D is an issuer notice filing. A filing does not mean the SEC approved, endorsed, or verified the offering.

In the news

RE Gain Acquires 176K-SF Tampa OfficesRE Gain Investment Fund LLC acquired Fountain Square III, a 176,150 SF Class A office building leased to JPMorgan Chase at 4900 Memorial Highway in Tampa, for $25.18M ($142/SF); CBRE represented seller Net Lease Office Properties.
CBRE Facilitates Sale of Fully Leased Office Building in TampaCBRE arranged the sale of Fountain Square III, a Class A 176,150-square-foot, four-story office building at 4900 Memorial Highway in Tampa, FL, leased to JPMorgan Chase, sold to Re Gain Investment Fund LLC; the deal closed Aug 19, 2025 with a $12.59M financing from Ameris Bank.

Frequently asked questions

Is Fountain Square III currently active?

Fountain Square III is part of the researched historical archive. “Active” reflects the latest public record and does not confirm that interests remain available.

Where does Top1031 get the data for Fountain Square III?

Top1031 tracks this offering from SEC Form D filings and cited sponsor disclosures. Filing data may lag current subscriptions and does not mean the SEC approved or verified the offering.